PTC Launches Arena AI Assistant to Accelerate PLM and QMS Workflows

  • Conversational AI assistant answers users' questions and delivers step-by-step guidance for all experience levels
  • Configurable interface conveniently embeds Arena AI Assistant in the context of product change and quality workflows
  • Available in multiple languages to support global engineering teams

PTC (NASDAQ: PTC) today announced the release of its Arena ® product lifecycle management (PLM) and quality management system (QMS) Artificial Intelligence (AI) Assistant, enabling teams to accelerate time to value. Arena AI Assistant delivers real-time, context-aware expertise rooted in best practices for PLM and QMS workflows in a conversational interface helping users navigate engineering change orders, manage corrective and preventive actions (CAPAs), maintain traceability and compliance, and much more. Arena AI Assistant is available directly in the Arena user interface and is powered by a comprehensive library of Arena Help materials and other resources.

"Arena AI Assistant is another example of how PTC is investing in Arena and equipping our users with the tools they need to help them be as productive as quickly as possible," said David Katzman , General Manager of Onshape and Arena. "Using Arena AI Assistant is like having an Arena expert working alongside you, helping you with the next step in a process or answering questions without the need to search through documentation or contact support. It's great for new and experienced users alike – whether it's the first stages of onboarding or navigating more complex engineering challenges."

Key features of Arena AI Assistant include:

  • Natural language interaction in a conversational interface, embedded directly in the Arena experience
  • Configurable within Arena interfaces to support guided steps through different workflows – from bill of material reviews and change orders to CAPAs and supply chain risk monitoring
  • Available in more than 15 languages to support global engineering teams
  • Updated with each new Arena release, keeping it up to date with the latest functionality and most efficient ways of working

In addition to the launch of Arena AI Assistant, this release strengthens supply chain resiliency through new Arena Supply Chain Intelligence (SCI) and Onshape-Arena Connection features. The Arena SCI™ offering continuously checks for emerging risks from evolving supply chain conditions and eliminates the need for disconnected supply chain tools by embedding real-time, AI-driven component monitoring and risk mitigation insight directly into product development workflows. The Onshape-Arena Connection enables mechanical engineers to seamlessly manage the release, revision, and change management process between CAD and PLM systems to help accelerate the product development process and simplify collaboration with supply chain partners.

For more on Arena AI Assistant, read this blog: How Arena's New AI Assistant Empowers PLM Users at Every Level .

About PTC
PTC (NASDAQ: PTC) is a global software company that enables manufacturers and product companies to digitally transform how they design, manufacture, and service the physical products that the world relies on. Headquartered in Boston, Massachusetts , PTC employs over 7,000 people and supports more than 30,000 customers globally. For more information, please visit www.ptc.com .

Media Contact
Greg Payne
gpayne@ptc.com

Investor Contact
Matt Shimao
mshimao@ptc.com

PTC, Arena, Arena Supply Chain Intelligence, Arena SCI, and the PTC logo are trademarks or registered trademarks of PTC Inc. and its subsidiaries in the United States and other countries.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/ptc-launches-arena-ai-assistant-to-accelerate-plm-and-qms-workflows-302556825.html

SOURCE PTC Inc.

News Provided by PR Newswire via QuoteMedia

PTC
The Conversation (0)
Stock Trend Capital

Stock Trend Capital Announces Loan to eGOD Digital Labs for Dogecoin Mining

Stock Trend Capital Inc. (CSE: PUMP) (FSE: P0G) (PTC Pink: STOCF) (the "Company" or "Stock Trend") announces that the Company has entered into a loan agreement (the "Loan Agreement") dated January 7, 2025, with 1001070426 Ontario Inc. dba eGOD Digital Labs ("eGod" or "the "Borrower"), whereby... Keep Reading...
Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy  Achieved or Maintained the Ability to Sit, Stand or Walk

Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy Achieved or Maintained the Ability to Sit, Stand or Walk

- After 5 years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected to live past 2 years of age - - 96% of Evrysdi-treated children could swallow, 80% could feed without a feeding tube and 59% could sit without support for at least 30... Keep Reading...
Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

News Summary: The new solution will combine Cisco and NVIDIA innovation to simplify the deployment of generative AI applications, providing IT visibility and analytics across the entire AI infrastructure stack. Cisco Nexus HyperFabric AI clusters make it easy for enterprise customers to build... Keep Reading...
Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

(TheNewswire) Brossard, Quebec, MAY 14, 2024 TheNewswire - Charbone Hydrogen Corporation (TSXV: CH; OTCQB: CHHYF; FSE: K47) (the "Company" or "CHARBONE"), North America's only publicly traded pure-play green hydrogen company, today announced that the Company has received a US$60.8 Million... Keep Reading...
"investingnews.com"

Northstar Applies to Cross Trade on the OTCQB Venture Market in the US

Northstar Clean Technologies Inc. (TSXV: ROOF) ("Northstar" or the "Company") announces that it has filed its application for its common shares to be cross traded on the OTCQB Venture Market (the "OTCQB"). The OTCQB market provides a platform for a wide variety of companies to be able to trade... Keep Reading...
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Latest Press Releases

Related News